OrbiMed Advisors as of Dec. 31, 2010
Portfolio Holdings for OrbiMed Advisors
OrbiMed Advisors holds 93 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genzyme Corporation | 5.5 | $152M | 2.1M | 71.20 | |
| Amgen (AMGN) | 4.9 | $136M | 2.5M | 54.90 | |
| Gilead Sciences (GILD) | 4.4 | $121M | 3.3M | 36.24 | |
| Merck & Co (MRK) | 4.3 | $119M | 3.3M | 36.04 | |
| Pfizer (PFE) | 3.9 | $109M | 6.2M | 17.51 | |
| Bristol Myers Squibb (BMY) | 3.8 | $105M | 4.0M | 26.48 | |
| BioMarin Pharmaceutical (BMRN) | 3.3 | $92M | 3.4M | 26.93 | |
| Shire | 3.3 | $91M | 1.3M | 72.38 | |
| Thermo Fisher Scientific (TMO) | 3.0 | $84M | 1.5M | 55.36 | |
| Allergan | 2.9 | $80M | 1.2M | 68.67 | |
| Illumina (ILMN) | 2.8 | $78M | 1.2M | 63.34 | |
| Warner Chilcott Plc - | 2.8 | $77M | 3.4M | 22.56 | |
| NxStage Medical | 2.4 | $67M | 2.7M | 24.88 | |
| Hospira | 2.2 | $61M | 1.1M | 55.69 | |
| Amarin Corporation | 2.2 | $60M | 7.3M | 8.20 | |
| Endo Pharmaceuticals | 2.1 | $60M | 1.7M | 35.71 | |
| WellPoint | 2.1 | $58M | 1.0M | 56.86 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $58M | 1.7M | 35.03 | |
| Celgene Corporation | 2.0 | $55M | 928k | 59.14 | |
| UnitedHealth (UNH) | 1.9 | $54M | 1.5M | 36.11 | |
| Human Genome Sciences | 1.7 | $48M | 2.0M | 23.89 | |
| Dendreon Corporation | 1.7 | $47M | 1.4M | 34.92 | |
| Baxter International (BAX) | 1.6 | $44M | 864k | 50.62 | |
| Elan Corporation | 1.6 | $44M | 7.6M | 5.73 | |
| Allos Therapeutics | 1.5 | $42M | 9.2M | 4.61 | |
| Watson Pharmaceuticals | 1.5 | $42M | 807k | 51.65 | |
| Alcon | 1.5 | $41M | 250k | 163.40 | |
| Johnson & Johnson (JNJ) | 1.3 | $36M | 581k | 61.85 | |
| Pharmacyclics | 1.2 | $34M | 5.6M | 6.08 | |
| Perrigo Company | 1.2 | $33M | 525k | 63.33 | |
| Momenta Pharmaceuticals | 1.2 | $32M | 2.2M | 14.97 | |
| Align Technology (ALGN) | 1.2 | $32M | 1.6M | 19.54 | |
| Complete Genomics | 1.1 | $31M | 4.2M | 7.47 | |
| MAP Pharmaceuticals | 0.9 | $25M | 1.5M | 16.74 | |
| NPS Pharmaceuticals | 0.9 | $25M | 3.1M | 7.90 | |
| Zimmer Holdings (ZBH) | 0.8 | $23M | 436k | 53.68 | |
| Insulet Corporation (PODD) | 0.8 | $23M | 1.5M | 15.50 | |
| Pharmasset | 0.8 | $22M | 507k | 43.56 | |
| Aetna | 0.8 | $22M | 727k | 30.51 | |
| Stryker Corporation (SYK) | 0.7 | $20M | 377k | 53.70 | |
| Given Imaging | 0.7 | $20M | 1.4M | 14.64 | |
| Incyte Corporation (INCY) | 0.7 | $20M | 1.2M | 16.56 | |
| Biogen Idec (BIIB) | 0.7 | $20M | 291k | 67.05 | |
| Abbott Laboratories (ABT) | 0.6 | $18M | 371k | 47.91 | |
| Medtronic | 0.6 | $18M | 480k | 37.09 | |
| Cephalon | 0.6 | $17M | 280k | 61.72 | |
| CIGNA Corporation | 0.6 | $17M | 467k | 36.66 | |
| Anthera Pharmaceuticals | 0.6 | $17M | 3.4M | 4.88 | |
| Sequenom | 0.6 | $17M | 2.1M | 8.03 | |
| Humana (HUM) | 0.6 | $15M | 280k | 54.74 | |
| AVEO Pharmaceuticals | 0.5 | $14M | 954k | 14.62 | |
| Antares Pharma | 0.4 | $10M | 6.1M | 1.70 | |
| Cubist Pharmaceuticals | 0.4 | $10M | 472k | 21.40 | |
| OraSure Technologies (OSUR) | 0.4 | $10M | 1.8M | 5.75 | |
| Affymetrix | 0.3 | $9.6M | 1.9M | 5.03 | |
| Teva Pharmaceutical Industries (TEVA) | 0.3 | $9.1M | 175k | 52.13 | |
| Boston Scientific Corporation (BSX) | 0.3 | $9.1M | 1.2M | 7.57 | |
| Inhibitex | 0.3 | $8.3M | 3.2M | 2.60 | |
| CareFusion Corporation | 0.3 | $8.1M | 315k | 25.70 | |
| Waters Corporation (WAT) | 0.3 | $7.8M | 100k | 77.71 | |
| Anadys Pharmaceuticals (ANDS) | 0.3 | $7.6M | 5.4M | 1.42 | |
| Ariad Pharmaceuticals | 0.3 | $7.5M | 1.5M | 5.10 | |
| Volcano Corporation | 0.2 | $6.2M | 228k | 27.31 | |
| Covidien | 0.2 | $5.9M | 130k | 45.66 | |
| Life Technologies | 0.2 | $5.8M | 105k | 55.50 | |
| 3SBio (SSRX) | 0.2 | $5.5M | 360k | 15.18 | |
| Hologic (HOLX) | 0.2 | $4.7M | 250k | 18.82 | |
| CUBIST PHARM CONVERTIBLE security | 0.2 | $4.9M | 5.0M | 0.97 | |
| Achillion Pharmaceuticals | 0.2 | $4.3M | 1.0M | 4.15 | |
| Athersys | 0.2 | $4.5M | 1.8M | 2.47 | |
| TomoTherapy Incorporated | 0.1 | $4.2M | 1.2M | 3.61 | |
| Ym Biosciences | 0.1 | $4.2M | 1.8M | 2.33 | |
| Vertex Pharmaceuticals Inc note 3.350%10/0 | 0.1 | $4.0M | 4.0M | 1.01 | |
| Volcano Corporation | 0.1 | $4.0M | 145k | 27.31 | |
| Seattle Genetics | 0.1 | $3.6M | 240k | 14.95 | |
| Syneron Medical Ltd ord | 0.1 | $3.7M | 364k | 10.19 | |
| Dendreon Corp cnv | 0.1 | $3.5M | 1.0M | 3.50 | |
| McKesson Corporation (MCK) | 0.1 | $2.8M | 40k | 70.38 | |
| Express Scripts | 0.1 | $2.7M | 50k | 54.06 | |
| Cytokinetics | 0.1 | $2.8M | 1.4M | 2.09 | |
| Covance | 0.1 | $2.5M | 48k | 51.42 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $2.5M | 250k | 9.86 | |
| Pacific Biosciences of California (PACB) | 0.1 | $2.5M | 160k | 15.91 | |
| InterMune | 0.1 | $1.9M | 52k | 36.40 | |
| AmSurg | 0.1 | $2.0M | 95k | 20.95 | |
| United Therapeutics Corporation (UTHR) | 0.1 | $2.0M | 31k | 63.23 | |
| Clinical Data (CLDA) | 0.1 | $2.0M | 125k | 15.91 | |
| Cynosure | 0.1 | $1.8M | 180k | 10.23 | |
| Orexigen Therapeutics | 0.1 | $1.6M | 200k | 8.08 | |
| Uroplasty | 0.1 | $1.5M | 380k | 4.03 | |
| Volcano Corporation note 2.875% 9/0 | 0.1 | $1.7M | 1.5M | 1.15 | |
| Solta Medical | 0.1 | $1.5M | 493k | 3.05 | |
| Medivation | 0.0 | $1.1M | 75k | 15.17 |
